Approvals galore was the theme of the week, as the US FDA issued a series of positive decisions in a long lineup of user fee goal dates. Here's your news in brief:
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?